These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


249 related items for PubMed ID: 19295186

  • 1. KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model.
    Siddique ZL, Drozdov I, Floch J, Gustafsson BI, Stunes K, Pfragner R, Kidd M, Modlin IM.
    Neuroendocrinology; 2009; 89(4):458-70. PubMed ID: 19295186
    [Abstract] [Full Text] [Related]

  • 2. The 5-HT(2B) receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment.
    Svejda B, Kidd M, Giovinazzo F, Eltawil K, Gustafsson BI, Pfragner R, Modlin IM.
    Cancer; 2010 Jun 15; 116(12):2902-12. PubMed ID: 20564397
    [Abstract] [Full Text] [Related]

  • 3. The functional characterization of normal and neoplastic human enterochromaffin cells.
    Modlin IM, Kidd M, Pfragner R, Eick GN, Champaneria MC.
    J Clin Endocrinol Metab; 2006 Jun 15; 91(6):2340-8. PubMed ID: 16537680
    [Abstract] [Full Text] [Related]

  • 4. Isolation, functional characterization, and transcriptome of Mastomys ileal enterochromaffin cells.
    Kidd M, Modlin IM, Eick GN, Champaneria MC.
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov 15; 291(5):G778-91. PubMed ID: 16455786
    [Abstract] [Full Text] [Related]

  • 5. Further delineation of the continuous human neoplastic enterochromaffin cell line, KRJ-I, and the inhibitory effects of lanreotide and rapamycin.
    Kidd M, Eick GN, Modlin IM, Pfragner R, Champaneria MC, Murren J.
    J Mol Endocrinol; 2007 Feb 15; 38(1-2):181-92. PubMed ID: 17242179
    [Abstract] [Full Text] [Related]

  • 6. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.
    Modlin IM, Gustafsson BI, Drozdov I, Nadler B, Pfragner R, Kidd M.
    Ann Surg Oncol; 2009 Feb 15; 16(2):487-98. PubMed ID: 19050963
    [Abstract] [Full Text] [Related]

  • 7. The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling.
    Leu FP, Nandi M, Niu C.
    Mol Cancer Res; 2008 Jun 15; 6(6):1029-42. PubMed ID: 18567806
    [Abstract] [Full Text] [Related]

  • 8. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
    Vitale G, van Koetsveld PM, de Herder WW, van der Wansem K, Janssen JA, Colao A, Lombardi G, Lamberts SW, Hofland LJ.
    Am J Physiol Endocrinol Metab; 2009 Mar 15; 296(3):E559-66. PubMed ID: 19141687
    [Abstract] [Full Text] [Related]

  • 9. Novel action of transforming growth factor beta 1 in functioning human pancreatic carcinoid cells.
    Ishizuka J, Beauchamp RD, Sato K, Townsend CM, Thompson JC.
    J Cell Physiol; 1993 Jul 15; 156(1):112-8. PubMed ID: 8391003
    [Abstract] [Full Text] [Related]

  • 10. Functional CRF receptors in BON cells stimulate serotonin release.
    von Mentzer B, Murata Y, Ahlstedt I, Lindström E, Martínez V.
    Biochem Pharmacol; 2007 Mar 15; 73(6):805-13. PubMed ID: 17184738
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anticancer activity of novel plant extracts from Trailliaedoxa gracilis (W. W. Smith & Forrest) in human carcinoid KRJ-I Cells.
    Svejda B, Aguiriano-Moser V, Sturm S, Höger H, Ingolic E, Siegl V, Stuppner H, Pfragner R.
    Anticancer Res; 2010 Jan 15; 30(1):55-64. PubMed ID: 20150617
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants.
    Kidd M, Modlin IM, Gustafsson BI, Drozdov I, Hauso O, Pfragner R.
    Am J Physiol Gastrointest Liver Physiol; 2008 Aug 15; 295(2):G260-72. PubMed ID: 18556422
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors.
    Kidd M, Schally AV, Pfragner R, Malfertheiner MV, Modlin IM.
    Cancer; 2008 Mar 15; 112(6):1404-14. PubMed ID: 18224665
    [Abstract] [Full Text] [Related]

  • 17. Regulation of mastomys ECL cell function by transforming growth factor alpha.
    Lawton GP, Tang L, Kidd M, Chinery R, Miu K, Modlin IM.
    J Surg Res; 1996 Feb 01; 60(2):293-302. PubMed ID: 8598657
    [Abstract] [Full Text] [Related]

  • 18. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.
    Baradari V, Huether A, Höpfner M, Schuppan D, Scherübl H.
    Endocr Relat Cancer; 2006 Dec 01; 13(4):1237-50. PubMed ID: 17158768
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of growth factors on proliferation and expression of growth factor receptors in a human lens epithelial cell line.
    Kampmeier J, Baldysiak-Figiel A, de Jong-Hesse Y, Lang GK, Lang GE.
    J Cataract Refract Surg; 2006 Mar 01; 32(3):510-4. PubMed ID: 16631066
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.